ESPR on the 120-minute chart is surging with momentum from an FDA approval for a new cholestrol and lipid medication which will be an alternative to the at statin class which has side effects and can cause diabetes. I am familar with a few of the professionals on the science advisory board they are researchers and academics of the highest claiber. The...
VINC on the 15 minute chart was sideways at the top and put in a 20% short trade today which was straightforward an easy. A 50% partial taken off at the mid-day counter trend then the remainder of 50% off before the close. Idea is on the chart; see also the previous ideas. Expecting a full reversal in the pre-market trading and a good intraday trade at least...
VINC went from 1.5 to 3.0 in less than three hours with 12X relative volume in the afternoon after a month of a slow climb from a news release that really did not amount to much. Insiders are 25% of the shareholders and that may be the story here. This could be manipulation at its finest. I have to wonder how many insiders bought how many shares and when the...
Here on the 30-minute chart is my idea for the continuation of my VINC idea posted here before the current breakout. Price is presently in a consolidation ascending regression channel . The choices for a play are to wait for a break above or below the channel or alternatively play the price action inside the channel. Since price is currently at the bottom of...
JAN had earnings but I cannot find the report. It is trading with heavy volume and it shows in the price action. Price has pulled back in the after-market in a standard Fibonacci retracement. A pullback is appropriate here as price has gained 250% in a month. I see the pullback as healthy and JAN is now well positioned for another bullish continuation....
With many pharma stocks with even larger market caps going up x10 over a 2 month period, this one can do x20.